Cellular Biomedicine initiates recruitment for myeloma study
Cellular Biomedicine announces the initiation of patient recruitment to support the study of anti-BCMA CAR-T therapy targeting relapsed and refractory Multiple Myeloma in China.
https://thefly.com/landingPageNews.php?id=2845893
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.